Alcon stock: BTIG cuts target for Alcon stock from USD 82.00 to USD 74.00

Published on 10/19/2026 at 17:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alcon reports third-quarter results on November 10, 2026. Alcon stock costs EUR 58.58 on October 19, 2026, down 0.91 percent versus the Xetra close.

Analyst targets and valuation

On October 12, 2026, BTIG lowered its Alcon target from USD 82.00 to USD 74.00.
Alcon is scheduled to release third-quarter results on November 10, 2026.
Alcon stock costs EUR 58.58 at Lang & Schwarz on October 19, 2026 at 5:02 p.m. CEST, minus 0.91 percent versus the Xetra close of October 16, 2026.
Alcon has a USD 31.8 billion market capitalization and a price-to-earnings ratio of 50.59.

Flat lay product photography on white marble. Contact lens case, lens solution bottle, soaking dish, and optometry trial lens kit arranged neatly with soft studio overhead lighting, clinical cleanliness, no text on items — Alcon CH0432492467: Flatlay mit Kontaktlinsenbehälter, Pflegelösung und Probierlinsen Set auf weißem Marmor, Illustration mit AI erstellt.

BTIG lowered its Alcon price target from USD 82.00 to USD 74.00 on October 12, 2026, while keeping a Buy rating, according to Markets Insider. The cut leaves the target 12.59 percent above Alcon's USD 65.72 home-market price on October 19, 2026.

Results date sets the next marker

Alcon's next scheduled earnings release is November 10, 2026, when the company is due to report third-quarter results. The date is listed in the company calendar on MarketScreener.

Price sits below the yearly high

Alcon's euro quotation was EUR 58.58 at Lang & Schwarz on October 19, 2026 at 5:02 p.m. CEST, minus 0.91 percent versus the Xetra close. The finance snapshot places the primary-market price at USD 65.72, between a 52-week low of USD 61.84 and a 52-week high of USD 87.64, both dated October 19, 2026. That puts the home-market price 6.28 percent above the low and 25.01 percent below the high.

Trading activity in the United States stood at 257,114 shares against an average volume of 1,809,757 shares on October 19, 2026. The smaller volume gives the session a quieter profile than Alcon's recent average, while the euro price remains below the Xetra close of October 16, 2026.

Valuation stays above peer levels

Alcon's market capitalization was USD 31.8 billion on October 19, 2026, and its price-to-earnings ratio was 50.59. The dividend yield was 0.01 percent. The valuation gap to the Cooper Companies is visible in the comparison block, although both companies operate in eye care.

Comparison with peers

Alcon: minus 0.91 percent, P/E 50.59, market capitalization USD 31.8 billion
The Cooper Companies (NASDAQ, USD): minus 0.74 percent, P/E 19.64, market capitalization USD 10.9 billion
SMI (SIX Swiss Exchange, CHF): minus 0.49 percent, index level CHF 14,321.00

Alcon's trading position

Alcon operates through Surgical and Vision Care and serves customers in more than 140 countries. Its current market picture combines a lower BTIG target, a scheduled November reporting date and a valuation well above the Cooper Companies' price-to-earnings ratio.

The euro quotation stood at EUR 58.58 at Lang & Schwarz on October 19, 2026 at 5:02 p.m. CEST, minus 0.91 percent versus the Xetra close of October 16, 2026. The further course of trading is shown by the continuously updated real-time quote of Alcon stock.